SZ 211 (Nevirapine Extended-Release 400 mg)
Pill with imprint SZ 211 is Yellow, Elliptical/Oval and has been identified as Nevirapine Extended-Release 400 mg. It is supplied by Sandoz Inc.
Nevirapine is used in the treatment of hiv infection; reduction of perinatal transmission of hiv and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SZ 211
Nevirapine Extended-Release
- Imprint
- SZ 211
- Strength
- 400 mg
- Color
- Yellow
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- NNRTIs
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Inc.
- National Drug Code (NDC)
- 00781-5893
- Inactive Ingredients
-
lactose monohydrate,
hypromellose 2208 (4000 mPa.s),
ferric oxide yellow,
magnesium stearate
Note: Inactive ingredients may vary.
More about nevirapine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (6)
- Drug images
- Pricing & coupons
- En español
- Drug class: NNRTIs
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.